Design Therapeutics (DSGN) Interest Coverage Ratio (2024 - 2026)

Design Therapeutics has reported Interest Coverage Ratio for 7 years, with the latest figure at 6.89 in Q2 2026.

• Interest Coverage Ratio for Q2 2026 came in at 6.89, up 12.54% year-over-year; the trailing twelve-month figure through Jun 2026 was 7.62 (down 3.64% YoY), and the FY2025 annual result was 0.0, up 53.41% from the prior year.
• Interest Coverage Ratio retreated to 6.89 in Q2 2026, from 5.87 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 0.0 in Q4 2022 and troughed at 8.51 in Q3 2025.
• A 5-year average of 5.51 and a median of 6.1 in 2024 frame the typical range for Interest Coverage Ratio.
• The widest annual swing landed in 2023, when Interest Coverage Ratio tumbled 19255.04%; it then grew 26.93% in 2026.
• A 5-year view of Interest Coverage Ratio shows it stood at 0.0 in 2022, then tumbled by 19255.04% to 0.36 in 2023, then slumped by 1676.66% to 6.33 in 2024, then tumbled by 31.29% to 8.31 in 2025, then increased by 17.14% to 6.89 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 6.89 in Q2 2026, 5.87 in Q1 2026, and 8.31 in Q4 2025.